Patent ID: 11931377
Assignee: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  G  F | IPC A  G

Claim 2:
3. A method for treating a pediatric patient who is experiencing oxygen desaturation associated with idiopathic pulmonary arterial hypertension, wherein the patient is not dependent on right-to-left shunting of blood, the method comprising:
evaluating the patient, or having the patient evaluated, to determine if the patient has pre-existing left ventricular dysfunction, and
(a) if the patient does not have pre-existing left ventricular dysfunction, administering to the patient 20 ppm inhaled nitric oxide for a length of time sufficient to improve oxygenation in the patient, and
(b) if the patient does have pre-existing left ventricular dysfunction, administering inhaled supplemental oxygen to the patient and excluding the patient from treatment with inhaled nitric oxide.